DR2 antigens are associated with severity of disease in toxic oil syndrome (TOS)

被引:10
作者
Cárdaba, B
Ezendam, J
Gallardo, S
del Pozo, V
Izquierdo, M
Martín, C
Cortegano, I
Aceituno, E
Rojo, M
Arrieta, I
Palomino, P
Posada, M
Lahoz, C
机构
[1] Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain
[2] Inst Salud Carlos III, CISAT, Madrid, Spain
来源
TISSUE ANTIGENS | 2000年 / 55卷 / 02期
关键词
toxic oil syndrome (TOS); DNA typing; paraffin-embedded tissues; HLA class II antigens; DR2; disease;
D O I
10.1034/j.1399-0039.2000.550202.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Toxic oil syndrome (TOS) was an epidemic which broke our in Spain in 1981, caused by the ingestion of rapeseed oil denatured with 2%, aniline and sold illegally as edible oil. More than 20,000 people were affected and mortality rate was 8.4%. Genetic susceptibility appears to be involved in the pathology of this disease. Several reports have described association between the chronic stage of the disease and DR DQ antigens (DR3, DR4, DR2 and DQ8). In the present work, we have reassessed the HLA class II antigens in a well-designed case-control study. Triplets uf subjects (n=265) compound by chronic patients (n=117), non-affected family members (n=71) and non-related controls (n=77) were studied. Also, HLA class II antigens were analyzed in patients who had died from TOS (n = 34) and in TOS control patients who died from other non-TOS related causes (n = 13). Regarding surviving patients no significant association was found between HLA and disease. In contrast, an increase in phenotypic frequency of DR2 antigen, was found in patients who had died from TOS (73.5%) compared with the whole study group: TOS-affected alive patients (25.6%, corrected P<0.001), non-affected family members (28.5%, corrected P<0.001), non-related controls (23.9%, corrected P<0.001) and dead controls (38.4%, P=0.03).
引用
收藏
页码:110 / 117
页数:8
相关论文
共 36 条
[1]   TOXIC OIL SYNDROME - A LONG-TERM FOLLOW-UP OF A COHORT OF 332 PATIENTS [J].
ALONSORUIZ, A ;
CALABOZO, M ;
PEREZRUIZ, F ;
MANCEBO, L .
MEDICINE, 1993, 72 (05) :285-295
[2]   Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome [J].
ArnaizVillena, A ;
MartinezLaso, J ;
Corell, A ;
Allende, L ;
Rosal, M ;
GomezReino, JJ ;
Vicario, JL .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1996, 23 (03) :211-219
[3]  
ARNAIZVILLENA A, 1982, NEW ENGL J MED, V307, P1404
[4]  
ARNAIZVILLENA A, 1982, P S NAC SIDR TOX, V1, P174
[5]   Investigation of specimen mislabelling in paraffin-embedded tissue using a rapid, allele-specific, PCR-based HLA class II typing method [J].
Bateman, AC ;
Sage, DA ;
AlTalib, RK ;
Theaker, JR ;
Jones, DB ;
Howell, WM .
HISTOPATHOLOGY, 1996, 28 (02) :169-174
[6]   Strain-dependent cytokine profile and susceptibility to oleic acid anilide in a murine model of the toxic oil syndrome [J].
Berking, C ;
Hobbs, MV ;
Chatelain, R ;
Meurer, M ;
Bell, SA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 148 (02) :222-228
[7]   GENOMIC ORGANIZATION OF CORE-2 AND I-BRANCHING BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASES - IMPLICATION FOR EVOLUTION OF THE BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE GENE FAMILY [J].
BIERHUIZEN, MFA ;
MAEMURA, K ;
KUDO, S ;
FUKUDA, M .
GLYCOBIOLOGY, 1995, 5 (04) :417-425
[8]   Toxic oil syndrome mortality:: the first 13 years [J].
Borda, IA ;
Philen, RM ;
de la Paz, MP ;
de la Cámara, AG ;
Ruiz-Navarro, MD ;
Ribota, OG ;
Soldevilla, JA ;
Terracini, B ;
Peña, SS ;
Leal, CF ;
Kilbourne, EM .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1998, 27 (06) :1057-1063
[9]   DR7 AND DQ2 ARE POSITIVELY ASSOCIATED WITH IMMUNOGLOBULIN-E RESPONSE TO THE MAIN ANTIGEN OF OLIVE POLLEN (OLE E I) IN ALLERGIC PATIENTS [J].
CARDABA, B ;
VILCHES, C ;
MARTIN, E ;
DEANDRES, B ;
DELPOZO, V ;
HERNANDEZ, D ;
GALLARDO, S ;
FERNANDEZ, JC ;
VILLALBA, M ;
RODRIGUEZ, R ;
BASOMBA, A ;
KREISLER, M ;
PALOMINO, P ;
LAHOZ, C .
HUMAN IMMUNOLOGY, 1993, 38 (04) :293-299
[10]  
DEANDRES B, 1995, BIOTECHNIQUES, V18, P42